sesame oil

Botanicalexperimental

Sesame oil is an edible vegetable oil derived from sesame seeds. The oil is one of the earliest-known crop-based oils. Worldwide mass modern production is limited due to the inefficient manual harvesting process required to extract the oil. Oil made from raw seeds, which may or may not be cold-pressed, is used as a cooking oil. Oil made from toasted seeds is used for its distinctive nutty aroma and taste, although it may be unsuitable for frying, which makes it taste burnt and bitter. — Wikipedia

Clinical trial activity

18 trials · 23 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
7
Phase 3
1
Phase 4
4

Earliest trial started Nov 1, 2006 (NCT00399165)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • sesame oil
  • sesame oil
  • sesame oil
  • sesame oil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06592144Phase 4Sep 9, 2024University of Sao Paulo
NCT06972134N/ADec 15, 2023Duhok University
NCT06151769N/ADec 1, 2023Erciyes University
NCT06327841N/AJun 21, 2022Medical University Innsbruck
NCT06375850N/AJun 5, 2022University of Bern, University of Cantabria
NCT07060053N/AMay 4, 2022Medical University Innsbruck
NCT05097651Phase 2Nov 30, 2021National Institute on Drug Abuse (NIDA), University of California, San Diego
NCT04749628Phase 4Sep 24, 2020Rockefeller University
NCT04120363Phase 4Sep 23, 2019Department of Defense, Pennington Biomedical Research Center, United States Army, University of Arkansas
NCT03826121N/AFeb 20, 2019Chonbuk National University
NCT03738176Early Phase 1 (Phase 1)Dec 16, 2018Cairo University
NCT01297400Phase 2Jan 2, 2018Skingenix, Inc.
NCT02734238Phase 4Apr 1, 2016Defence Research and Development Canada, Department of Defense, MyoSyntax, United States Army, University of Vermont
NCT01070433Phase 2Sep 1, 2012Skingenix, Inc., University of Miami
NCT01688479Phase 3Feb 1, 2011Karolinska Institute
NCT01154374Phase 2Nov 1, 2010Skingenix, Inc., University of Miami
NCT01138436Phase 2Nov 1, 2010Skingenix, Inc., University of Miami
NCT00399165Phase 1/Phase 2 (Phase 2)Nov 1, 2006GlaxoSmithKline, University of Washington
Showing 18 of 18 trials
Page 1 / 1

Organizations

Research & Development (23)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Skingenix, Inc.For profit4412010
University of MiamiAcademic/Hospital3012010
Department of DefenseGovernment2012016
Medical University InnsbruckAcademic/Hospital2212022
United States ArmyGovernment2012016
Cairo UniversityAcademic/Hospital1112018
Chonbuk National UniversityAcademic/Hospital1112019
Defence Research and Development CanadaGovernment1012016
Duhok UniversityAcademic/Hospital1112023
Erciyes UniversityAcademic/Hospital1112023
GlaxoSmithKlineFor profit1012006
Karolinska InstituteAcademic/Hospital1112011
MyoSyntaxFor profit1012016
National Institute on Drug Abuse (NIDA)Government1012021
Pennington Biomedical Research CenterAcademic/Hospital1112019
Rockefeller UniversityAcademic/Hospital1112020
University of ArkansasAcademic/Hospital1012019
University of BernAcademic/Hospital1012022
University of California, San DiegoAcademic/Hospital1112021
University of CantabriaAcademic/Hospital1112022
23 organizations
Page 1 / 2